Defunct Company
Total Trials
19
As Lead Sponsor
0
As Collaborator
Total Enrollment
5,129
NCT02678572
Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma
Phase: Phase 3
Role: Collaborator
Start: Feb 1, 2016
Completion: Aug 15, 2023
NCT03464019
Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).
Start: Jun 18, 2018
Completion: Jan 20, 2023
NCT03466320
DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2
Phase: Phase 1/2
Start: Sep 18, 2018
Completion: Feb 1, 2021
NCT03666780
Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study
Phase: N/A
Start: Nov 16, 2018
Completion: Sep 30, 2024
NCT03956355
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)
Start: May 21, 2019
Completion: May 26, 2020
NCT03983980
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)
Start: Jun 6, 2019
Completion: May 29, 2020
NCT04053387
Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)
Start: Aug 13, 2019
Completion: Apr 6, 2021
NCT04072835
Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
Start: Sep 23, 2019
Completion: Jan 26, 2023
NCT04123574
A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
Phase: Early Phase 1
Start: Oct 15, 2019
Completion: Dec 6, 2021
NCT04167137
Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants
Phase: Phase 1
Start: Dec 12, 2019
Completion: Dec 9, 2021
NCT04396340
First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b
Start: May 11, 2020
Completion: Sep 30, 2022
NCT04188574
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
Phase: Phase 2
Start: Mar 22, 2021
Completion: Jun 28, 2023
NCT04720378
Safety and Tolerability Study of IV ST266 in COVID-19 Subjects
Start: May 30, 2021
Completion: May 3, 2022
NCT04907968
Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer
Start: Jun 11, 2021
Completion: Oct 3, 2023
NCT05414422
A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD
Start: Feb 1, 2022
Completion: Nov 10, 2022
NCT05030831
Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE
Start: Apr 11, 2022
Completion: Jul 9, 2024
NCT05066698
ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects
Start: Apr 27, 2022
Completion: Sep 7, 2022
NCT05908084
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
Start: Sep 7, 2023
Completion: Oct 31, 2027
NCT06549946
Ixovex-1 Single Agent and Combination Therapy
Start: Dec 17, 2024
Completion: Jan 30, 2027